Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Exicure Charts.

Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Exicure Charts.

Exicure Inc News

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
Thursday 26 December 2024 (1 week ago) • Business Wire

Form 8-K - Current report
Thursday 26 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Thursday 26 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Monday 23 December 2024 (1 week ago) • Edgar (US Regulatory)

CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
Saturday 21 December 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
Friday 20 December 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 2 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Friday 29 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (1 month ago) • Edgar (US Regulatory)

More Exicure Inc News Articles

Accredited Solutions (PK)

Quantum eMotion (QB)

TPT Global Tech (CE)

Fannie Mae (QB)

Valiant Eagle (PK)

RespireRx Pharmaceuticals (CE)

Apple Rush (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions